Non-invasive Liver Fibrosis Screening on CT Images using Radiomics
This provides a non-invasive screening tool for liver fibrosis, potentially enabling earlier detection, but it is incremental as it applies existing radiomics methods to a specific medical imaging task.
The study developed a radiomics machine learning model to detect liver fibrosis on CT images, achieving an AUC of 0.7833 with high sensitivity of 0.9091 on non-contrast enhanced CT.
Objectives: To develop and evaluate a radiomics machine learning model for detecting liver fibrosis on CT of the liver. Methods: For this retrospective, single-centre study, radiomic features were extracted from Regions of Interest (ROIs) on CT images of patients who underwent simultaneous liver biopsy and CT examinations. Combinations of contrast, normalization, machine learning model, and feature selection method were determined based on their mean test Area Under the Receiver Operating Characteristic curve (AUC) on randomly placed ROIs. The combination and selected features with the highest AUC were used to develop a final liver fibrosis screening model. Results: The study included 101 male and 68 female patients (mean age = 51.2 years $\pm$ 14.7 [SD]). When averaging the AUC across all combinations, non-contrast enhanced (NC) CT (AUC, 0.6100; 95% CI: 0.5897, 0.6303) outperformed contrast-enhanced CT (AUC, 0.5680; 95% CI: 0.5471, 0.5890). The combination of hyperparameters and features that yielded the highest AUC was a logistic regression model with inputs features of maximum, energy, kurtosis, skewness, and small area high gray level emphasis extracted from non-contrast enhanced NC CT normalized using Gamma correction with $γ$ = 1.5 (AUC, 0.7833; 95% CI: 0.7821, 0.7845), (sensitivity, 0.9091; 95% CI: 0.9091, 0.9091). Conclusions: Radiomics-based machine learning models allow for the detection of liver fibrosis with reasonable accuracy and high sensitivity on NC CT. Thus, these models can be used to non-invasively screen for liver fibrosis, contributing to earlier detection of the disease at a potentially curable stage.